We’re really excited to see the latest paper from Jerome Tamburini and colleagues published just last month in Leukemia journal.
In this study, Tamburini et al. investigated how mitochondrial metabolism is linked to acute myeloid leukemia (AML). Using patient-derived xenograft models, they found that blocking mitochondrial fusion resulted in anti-leukemic cellular activity, with minimal impact on normal hematopoietic cells.
You can find out more about the underlying mechanisms of this intriguing process, here: https://lnkd.in/eWvwR65h
IEL offers congratulations to all those involved in this impactful study. It’s exciting to see that inhibiting mitochondrial fusion might one day constitute a potential therapeutic approach for those with AML.